Active Ingredient History
Fulranumab is a monoclonal antibody against nerve growth factor. It was designed for the treatment of pain. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Arthralgia (Phase 2)
Chronic Pain (Phase 1)
Cystitis (Phase 2)
Cystitis, Interstitial (Phase 2)
Diabetic Neuropathies (Phase 2)
Low Back Pain (Phase 2)
Mononeuropathies (Phase 2)
Neuralgia (Phase 2)
Neuralgia, Postherpetic (Phase 2)
Osteoarthritis (Phase 3)
Osteoarthritis, Hip (Phase 2)
Osteoarthritis, Knee (Phase 2)
Pain (Phase 3)
Urinary Bladder Diseases (Phase 2)
Urologic Diseases (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue